Skip to main content
. 2022 Oct 17;62(6):2294–2303. doi: 10.1093/rheumatology/keac574

Figure 3.

Figure 3.

CD4+ and CD8+ T cell responses to SARS-CoV-2 peptides in antibody high and antibody no/low RAIRD patients. (A) Spike-specific CD4+ T cells were significantly higher in the antibody high patients and there were no detectable nucleocapsid-specific CD4+ T cells. (B) No difference in total cytokine-positive spike-specific CD4+ T cells. (C) Cytokine patterns expressed by spike and nucleocapsid-specific CD4+ T cells. (D) Higher spike-specific CD8+ T cells in antibody high patients. (E) No difference in total cytokine-positive spike-specific CD8+ T cells. (F) Cytokine patterns expressed by spike and nucleocapsid-specific CD8+ T cells